Correction
for
Rosack, Psychiatr News 37 (12) 24.
Psychiatric News July 19, 2002
Volume 37 Number 14
© 2002 American Psychiatric Association
p. 25
Erratum
In the the article "New Antipsychotic Boasts Better Side-Effect Profile" in the June 21 issue, the discovery and development of a new antipsychotic drug, aripiprazole, were attributed solely to Bristol-Myers Squibb Company (BMS). Aripiprazole was originally discovered by Otsuka Pharmaceutical Company Ltd. of Japan. Otsuka and BMS then codeveloped the drug and will promote the medication under the proposed brand name Abilitat, for the treatment of schizophrenia, pending FDA approval. 
Get information about faster international access.
Privacy Policy
Copyright © 2002
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
